Clinical trial explores effects of intravenous iron on chronic heart failure

Pharmacosmos’ initiates first hard endpoint randomised controlled trial looking at the effect of intravenous (IV) iron in chronic heart failure (CHF) Read more

8 Jun 2016 16:52 News